​
​

Checkpoint Therapeutics (CKPT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Checkpoint Therapeutics Revenue Highlights

Latest Revenue (Y)

$103.00K

0

Main Segment (Y)

PD-L1 GITR

Main Geography (Y)

PD-L1 GITR

Checkpoint Therapeutics Revenue by Period

Checkpoint Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--46.35%
2022-12-31--28.36%
2021-12-31--74.93%
2020-12-31--37.41%
2019-12-31--51.28%
2018-12-31-103.25%
2017-12-31--32.88%
2016-12-31-335.59%
2015-12-31--

Checkpoint Therapeutics generated $103.00K in revenue during NA 2023, up -46.35% compared to the previous quarter, and up 2.94% compared to the same period a year ago.

Checkpoint Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31--80.65%
2023-09-30--
2023-06-30--11.43%
2023-03-31--52.70%
2022-12-31-54.17%
2022-09-30-166.67%
2022-06-30--65.38%
2022-03-31-225.00%
2021-12-31--44.83%
2021-09-30--81.29%
2021-06-30-127.94%
2021-03-31-151.85%
2020-12-31--3.57%
2020-09-30--33.33%
2020-06-30--95.68%
2020-03-31-3788.00%
2019-12-31--91.07%
2019-09-30--73.36%
2019-06-30-198.58%
2019-03-31--88.39%
2018-12-31-60520.00%
2018-09-30--96.06%
2018-06-30--62.97%
2018-03-31-3.31%
2017-12-31--4.87%
2017-09-30--0.57%
2017-06-30--49.35%
2017-03-31-39.16%
2016-12-31--8.79%
2016-09-30--56.29%
2016-06-30-350.90%
2016-03-31-326.15%
2015-12-31-160.00%
2015-09-30--

Checkpoint Therapeutics generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Checkpoint Therapeutics Revenue Breakdown

Checkpoint Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21Dec 20Dec 19
PD-L1 GITR---
Pd L1---

Checkpoint Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: PD-L1 GITR (100.00%).

Checkpoint Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20Dec 19
PD-L1 GITR---
Pd L1---

Checkpoint Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: PD-L1 GITR (100.00%).

Checkpoint Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics--
SPROSpero Therapeutics--
FBIOFortress Biotech--
PIRSPieris Pharmaceuticals--
ASMBAssembly Biosciences--
CUECue Biopharma--
LUMOLumos Pharma--
CKPTCheckpoint Therapeutics--
MBIOMustang Bio--
RVPHReviva Pharmaceuticals--
TILInstil Bio--
ALRNAileron Therapeutics--
MDNAMedicenna Therapeutics--
NLTXNeurogene--
ACHLAchilles Therapeutics--
ATXIAvenue Therapeutics--
KODKodiak Sciences--

CKPT Revenue FAQ

What is Checkpoint Therapeutics’s yearly revenue?

Checkpoint Therapeutics's yearly revenue for 2023 was $103K, representing a decrease of -46.35% compared to 2022. The company's yearly revenue for 2022 was $192K, representing a decrease of -28.36% compared to 2021. CKPT's yearly revenue for 2021 was $268K, representing a decrease of -74.93% compared to 2020.

What is Checkpoint Therapeutics’s quarterly revenue?

Checkpoint Therapeutics's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $41K, a 100.00% increase from the previous quarter (Q1 2024), and a 32.26% increase year-over-year (Q2 2023). CKPT's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is Checkpoint Therapeutics’s revenue growth rate?

Checkpoint Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -61.57%, and for the last 5 years (2019-2023) was -93.97%.

What are Checkpoint Therapeutics’s revenue streams?

Checkpoint Therapeutics's revenue streams in c 21 are PD-L1 GITR

What is Checkpoint Therapeutics’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Checkpoint Therapeutics was PD-L1 GITR. This segment made a revenue of $21.5M, representing 100.00% of the company's total revenue.